GSDMD and COVID-19: A recent paper highlighted that antibody-opsonized respiratory syndrome coronavirus 2 (SARS-CoV-2) virions triggered inflammation and pyroptosis in human blood monocytes of patients with COVID-19 via the NLRP3/AIM2 inflammasome pathway leading to caspase-1 and GSDMD processing.